Advertisement

Our Best Bets for Treating COVID-19

Our Best Bets for Treating COVID-19 While this episode was in production, preliminary data from a clinical trial for remdesivir was leaked to the press; while the results look promising, it’s important to note the researchers haven’t formally published their results yet.


About a combination of chloroquine and hydroxychloroquine:

our COVID-19 playlist:

It will probably be at least a year before we have a vaccine for COVID-19. But in March, the WHO launched a megatrial tolook at four treatment options for the virus.

Hosted by: Hank Green

SciShow has a spinoff podcast! It's called SciShow Tangents. Check it out at
----------
Support SciShow by becoming a patron on Patreon:
----------
Huge thanks go to the following Patreon supporters for helping us keep SciShow free for everyone forever:

Kevin Bealer, Jacob, Katie Marie Magnone, D.A.Noe, Charles Southerland, Eric Jensen, Christopher R Boucher, Alex Hackman, Matt Curls, Adam Brainard, Scott Satovsky Jr, Sam Buck, Ron Kakar, Chris Peters, Kevin Carpentier, Patrick D. Ashmore, Piya Shedden, Sam Lutfi, charles george, Greg

----------
Looking for SciShow elsewhere on the internet?
Facebook:
Twitter:
Tumblr:
Instagram:
----------
Sources:



















Image Sources:








SciShow,science,Hank,Green,education,learn,Our Best Bets for Treating COVID-19,COVID-19,coronavirus,virus,SARS-CoV-2,SOLIDARITY,WHO,megatrial,chloroquine,hydroxychloroquine,remdesivir,RNA viruses,polymerase,adenosine,DNA,RNA,compassionate use program,ritonavir,lopinavir,HIV protease inhibitor,HIV,interferon-beta,MERS,

Post a Comment

0 Comments